Not applicableActive Not RecruitingNCT06310499What this trial is testingPrimary or Secondary DrowningWho this might be right forDrowningDrowning; AnoxiaDrowning, Near+10 more Prehospital Center, Region Zealand 700
Not applicableStudy completedNCT03281499What this trial is testingTransoral Robotic Surgery and Tailored Radiotherapy in Unknown Primary and Small Squamous Cell Head and Neck CancerWho this might be right forHead and Neck Squamous Cell Carcinoma University Health Network, Toronto 22
Not applicableStudy completedNCT00745381What this trial is testingA Collection of Clinical and Epidemiologic Data Combined With Tissue and Blood From Patients With a Diagnosis of Neuroendocrine TumorsWho this might be right forGastric CancerPancreatic Cancer Memorial Sloan Kettering Cancer Center 238
Early research (Phase 1)Ended earlyNCT00112619What this trial is testingTopotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid TumorsWho this might be right forBrain and Central Nervous System TumorsCarcinoma of Unknown PrimaryLeukemia+2 more Pediatric Brain Tumor Consortium 19
Early research (Phase 1)Study completedNCT00003548What this trial is testingAminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal CavityWho this might be right forCancer NYU Langone Health 20
Testing effectiveness (Phase 2)Study completedNCT04133948What this trial is testingMulticenter Phase 1b Trial Testing the Neoadjuvant Combination of Domatinostat, Nivolumab and Ipilimumab in IFN-gamma Signature-low and IFN-gamma Signature-high RECIST 1.1-measurable Stage III Cutaneous or Unknown Primary MelanomaWho this might be right forMalignant Melanoma Stage III The Netherlands Cancer Institute 44
Large-scale testing (Phase 3)Active Not RecruitingNCT00588770What this trial is testingChemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaWho this might be right forNeck Squamous Cell Carcinoma of Unknown PrimaryRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+32 more National Cancer Institute (NCI) 403
Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Testing effectiveness (Phase 2)Study completedNCT00353015What this trial is testingIrinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal TractWho this might be right forGastrointestinal CancerCarcinoma, Neuroendocrine M.D. Anderson Cancer Center 21
Large-scale testing (Phase 3)Active Not RecruitingNCT01274338What this trial is testingIpilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by SurgeryWho this might be right forMelanoma of Unknown PrimaryRecurrent MelanomaStage IIIB Cutaneous Melanoma AJCC v7+2 more National Cancer Institute (NCI) 1,673
Large-scale testing (Phase 3)UnknownNCT00003558What this trial is testingChemotherapy in Treating Patients With Cancer of Unknown Primary OriginWho this might be right forCarcinoma of Unknown Primary Academisch Ziekenhuis Maastricht 140
Testing effectiveness (Phase 2)Looking for participantsNCT05576974What this trial is testingA Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)Who this might be right forHead and Neck CancerUnknown Primary CancerHead and Neck Squamous Cell Carcinoma University of Texas Southwestern Medical Center 120
Not applicableUnknownNCT04025970What this trial is testingMolecular Analysis of Blood Samples in Standardized Cancer Care Referrals for SCAN and CUPWho this might be right forNeoplasms, Unknown PrimaryCancer Christer Ericsson 200
Not applicableUnknownNCT05263700What this trial is testingFAPI-CUP- Evaluating FAPI as a Novel Radiopharmaceutical for Cancer of Unknown PrimaryWho this might be right forCancer of Unknown Primary Site Peter MacCallum Cancer Centre, Australia 150
Testing effectiveness (Phase 2)Study completedNCT00936221What this trial is testingComparison of AZD6244 in Combination With Dacarbazine Versus (vs) Dacarbazine Alone in BRAF Mutation Positive Melanoma PatientsWho this might be right forMelanoma AstraZeneca 385
Not applicableEnded earlyNCT00965861What this trial is testingSCRI Tissue Testing RegistryWho this might be right forMelanomaMyelodysplastic SyndromeMultiple Myeloma+1 more SCRI Development Innovations, LLC 20
Early research (Phase 1)Study completedNCT00014456What this trial is testingCombination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid TumorsWho this might be right forBladder CancerBreast CancerCarcinoma of Unknown Primary+9 more Dartmouth-Hitchcock Medical Center 35
Early research (Phase 1)Looking for participantsNCT07118176What this trial is testingDetermining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic CancersWho this might be right forAnal CarcinomaBladder CarcinomaBreast Carcinoma+31 more Jonsson Comprehensive Cancer Center 30
Large-scale testing (Phase 3)UnknownNCT00022178What this trial is testingCombination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of OriginWho this might be right forCarcinoma of Unknown Primary The Christie NHS Foundation Trust
Testing effectiveness (Phase 2)Ended earlyNCT00148135What this trial is testingCombination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary SiteWho this might be right forCarcinoma of Unknown Primary University of Michigan Rogel Cancer Center